Navidea Biopharmaceutical Stock (OTC: NAVB) stock price, news, charts, stock research, profile.
Open | $0.033 |
Close | $0.037 |
Volume / Avg. | 64.218K / 116.160K |
Day Range | 0.033 - 0.041 |
52 Wk Range | 0.021 - 0.330 |
Market Cap | $3.653M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | OTC |
RSI | 0 |
Short Interest | - |
Days to Cover | 1.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Navidea Biopharmaceutical (OTCPK: NAVB) through any online brokerage.
There are no as such competitors for Navidea Biopharmaceutical.
The latest price target for Navidea Biopharmaceutical (OTCPK: NAVB) was reported by HC Wainwright & Co. on Monday, August 17, 2020. The analyst firm set a price target for 8.00 expecting NAVB to rise to within 12 months (a possible 21817.81% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Navidea Biopharmaceutical (OTCPK: NAVB) is $0.0365 last updated March 28, 2024 at 3:06 PM EDT.
There are no upcoming dividends for Navidea Biopharmaceutical.
Navidea Biopharmaceutical does not have any upcoming earnings scheduled.
There is no upcoming split for Navidea Biopharmaceutical.
Navidea Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.